| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing crotamiton and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing dimeticone and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing econazole and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing hydrocortisone and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing hydrocortisone and miconazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing hydrocortisone and neomycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing hydrocortisone and nystatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing hydrocortisone and oxytetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing hydrocortisone and potassium hydroxyquinoline sulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing hydrocortisone and urea (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing lidocaine and methylprednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing methylprednisolone and neomycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing chlortetracycline and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing neomycin and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing nystatin and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing econazole and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing precisely clobetasol propionate 500 microgram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Hydrocortisone 5 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing precisely hydrocortisone 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| dexamethason 0,1 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| prednisolon 0,001 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| prednisolon 0,003 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| prednisolon 0,01 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| prednisolon 0,01 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| prednisolon 0,03 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| prednisolon 0,03 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| prednisolon 0,1 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| prednisolon 0,1 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| prednisolon 0,3 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| prednisolon 0,3 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing precisely prednisolone acetate 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Clobetasol propionate 500 microgram/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Hydrocortisone 10 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| hydrocortisonacetat pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| clobetasolpropionat 0,05 % til anvendelse i hårbunden |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Prednisolone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| betamethason til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| beclomethason til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| budesonid til respiratorisk anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| budesonid til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| beclometason til respirationssystemet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| prednisolon 20 mg rektalskum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Beclometasone-containing product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Betamethasone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Betamethasone-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing budesonide in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing dexamethasone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing dexamethasone in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| dexamethason til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| kombinationspræparat med dexamethason til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| fluticason til respirationssystemet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Fluticasone-containing product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| fluticason til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| hydrocortison øjensalve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Hydrocortisone-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| kombinationspræparat med hydrocortison til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Hydrocortisone-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Hydrocortisone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Methylprednisolone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing methylprednisolone in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Prednisolone-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| predinsolon til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| prednisolondråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Prednisolone-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing triamcinolone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Triamcinolone-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| triamcinolon til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Hydrocortisone 5 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| corticosteroider til anvendelse ved behandling af astma |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| prednisolonnatriumphosphat 0,5 % øjen-/øredråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Budesonide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing triamcinolone in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| hydrocortisonacetat 1,5 % + neomycinsulfat 0,5 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| halobetasolpropionatpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| fludrocortisonacetatpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing beclometasone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing paramethasone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| triamcinolondiacetatpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing fluocinonide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| betamethasonacetatpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing aldosterone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| glukokortikoidpræparat til systemisk anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| kortikosteroid til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| kortikosteroid til topikal anvendelse, gruppe II |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing methylprednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing fluocinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing halcinonide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing betamethasone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing flumetasone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| beclometasondipropionatpræparat opløsning til nasal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| cortisonacetatpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing hydrocortisone in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing hydrocortamate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| beclometasondipropionatpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing fluprednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing dexamethasone in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| mometasonfuroat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|
| Product containing flunisolide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
binyrehormonmiddel |
Inferred relationship |
Some |
|